Merck KGaA, Darmstadt (Germany)
In research, Merck KGaA, Darmstadt (Germany) stands highest in Physical Sciences (#2,715 of 10,670 worldwide), Health Sciences (#2,637 of 9,902 worldwide) and Medicine (#2,395 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology (Oncology is 6.7× its share of world research).
- World rank, 2022-now
- #3,875 of 22,385 · #2,000 all time
- Rank in Germany
- #144 of 795
- Research works
- 3.8k ▼ 8% vs 2018-21
- Citations
- 98k 25.6 per fractional work
- Top-10% rate
- 12.5% all institutions 10.0%
- vs its own fields
- 1.10× 1.00× is exactly expected
- Open access
- 29% world 40%
- International
- 34% world 18%
What is Merck KGaA, Darmstadt (Germany) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Physical SciencesDomain | #2,715 of 10,670 | 10.1% | 141 | #2198 | |
| Health SciencesDomain | #2,637 of 9,902 | 13.4% | 220 | #1529 | |
| MedicineField | #2,395 of 8,541 | 13.4% | 208 | #1434 | |
| Life SciencesDomain | #2,133 of 6,403 | 14.2% | 138 | #1632 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,252 of 2,964 | 15.0% | 91 | #1361 | |
| Molecular BiologySubfield | #1,023 of 1,880 | 12.8% | 65 | #1170 |
Each strip is that field's whole ranked pool, with the notch where Merck KGaA, Darmstadt (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Physical Sciences#2,198 #2,715
- Health Sciences#1,529 #2,637
- Medicine#1,434 #2,395
- Life Sciences#1,632 #2,133
- Biochemistry, Genetics and Molecular Biology#1,361 #1,252
- Molecular Biology#1,170 #1,023
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Merck KGaA, Darmstadt (Germany) work in?
In 2022-now, 41% of research at Merck KGaA, Darmstadt (Germany) is in Health Sciences, 27% in Physical Sciences. Its largest fields are Medicine (38%), Biochemistry, Genetics and Molecular Biology (17%), Engineering (11%). It does 2.0× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences23640.6%
- Medicine22438.4%
- Health Professions81.5%
- Veterinary40.6%
- Nursing10.1%
- Dentistry00.0%
- Physical Sciences15526.7%
- Engineering6210.6%
- Materials Science244.0%
- Chemistry223.8%
- Computer Science172.9%
- Environmental Science132.2%
- Mathematics71.2%
- Physics and Astronomy61.1%
- Chemical Engineering30.5%
- Energy20.3%
- Earth and Planetary Sciences00.1%
- Life Sciences15426.4%
- Social Sciences376.4%
What does Merck KGaA, Darmstadt (Germany) specialise in?
Where its research is concentrated relative to its size: Oncology takes 6.7× the share of its output that it takes of world research.
- OncologySubfield · 43.7 works6.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.1×. Every wedge is a field page.
All 26 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.13×19 works
- Veterinary4.57×4 works
- Immunology and Microbiology3.88×23 works
- Biochemistry, Genetics and Molecular Biology3.26×101 works
- Chemistry2.41×22 works
- Medicine2.00×224 works
- Economics, Econometrics and Finance1.43×18 works
- Chemical Engineering1.30×3 works
- Materials Science1.16×24 works
- Mathematics1.03×7 works
- Engineering0.71×62 works
- Decision Sciences0.57×3 works
- Health Professions0.55×8 works
- Neuroscience0.50×5 works
- Physics and Astronomy0.48×6 works
- Environmental Science0.45×13 works
- Computer Science0.38×17 works
- Business, Management and Accounting0.34×6 works
- Energy0.29×2 works
- Agricultural and Biological Sciences0.23×6 works
- Nursing0.19×0 works
- Social Sciences0.11×8 works
- Dentistry0.06×0 works
- Psychology0.06×1 works
- Earth and Planetary Sciences0.05×0 works
- Arts and Humanities0.03×1 works
- Pharmacology, Toxicology and Pharmaceutics 9.1×
- Veterinary 4.6×
- Immunology and Microbiology 3.9×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Chemistry 2.4×
- Medicine 2.0×
- Economics, Econometrics and Finance 1.4×
- Chemical Engineering 1.3×
- Materials Science 1.2×
- Mathematics 1.0×
- Engineering 0.7×
- Decision Sciences 0.6×
- Health Professions 0.6×
- Neuroscience 0.5×
- Physics and Astronomy 0.5×
- Environmental Science 0.5×
- Computer Science 0.4×
- Business, Management and Accounting 0.3×
- Energy 0.3×
- Agricultural and Biological Sciences 0.2×
- Nursing 0.2×
- Social Sciences 0.1×
- Dentistry 0.1×
- Psychology 0.1×
- Earth and Planetary Sciences 0.1×
- Arts and Humanities 0.0×
Who are the top researchers at Merck KGaA, Darmstadt (Germany)?
Ranked on the quality score, Simon L. Goodman, Frank T. Zenke and Salvatore Longobardi lead among researchers whose main affiliation is Merck KGaA, Darmstadt (Germany).
- 1
Simon L. Goodman
Germany · #123,255 worldwide 16k citations · 175 works
- 2
Frank T. Zenke
Germany · #169,119 worldwide 4.1k citations · 356 works
- 3
Salvatore Longobardi
Germany · #185,667 worldwide 3.9k citations · 107 works
- 4
Matthias Frech
Germany · #215,618 worldwide 6.4k citations · 46 works
- 5
Friedhelm Bladt
Germany · #217,354 worldwide 7.1k citations · 121 works
- 6
Kevin M. Chin
Germany · #229,149 worldwide 7.5k citations · 102 works
- 7
Brian Elenbaas
Germany · #229,477 worldwide 7.5k citations · 56 works
- 8
Anja von Heydebreck
Germany · #241,418 worldwide 11k citations · 121 works
- 9
Wenjing Zheng
Germany · #250,031 worldwide 4.5k citations · 106 works
- 10
Lukas Friedrich
Germany · #257,872 worldwide 1.8k citations · 71 works
Which keywords describe research at Merck KGaA, Darmstadt (Germany)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Immunotherapy, Targeted Therapy, Molecular Characterization and Prognostic Factors.
- PET Imaging
- Mammalian Cells
- Refolding
- Protein Aggregation
- Pharmacokinetics
- Recombinant Proteins
- ALK Inhibitors
- Metastatic
- Resistance Mechanisms
- Bladder Cancer
- Immunogenicity
- Biopharmaceuticals
- Medicinal Chemistry
- Fc Receptors
- Tumor Microenvironment
- Prognostic Factors
- Clinical Trials
- Cancer
- Immunotherapy
- Monoclonal Antibodies
- Chemotherapy
- Glycosylation
- Therapeutic Antibodies
- Targeted Therapy
- Molecular Characterization
- Cancer Therapy
- Antibody Engineering
- Monoclonal Antibody
- Neoadjuvant Therapy
- Guidelines
- Cell Culture
- Urothelial Carcinoma
- Genomic Profiling
- Treatment Guidelines
- EGFR Mutations
- Genomic Instability
- Stability
- Chromatography
- Biopharmaceutical Production
- Recombinant Protein
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy36▲ 8.8×18 topics
- Monoclonal Antibodies28▲ 54×3 topics
- Glycosylation27▲ 42×3 topics
- Immunotherapy26▲ 6.2×15 topics
- Therapeutic Antibodies25▲ 61×2 topics
- Cancer23▲ 2.9×39 topics
- Targeted Therapy22▲ 17×5 topics
- Clinical Trials19▲ 4.9×9 topics
- Molecular Characterization19▲ 18×4 topics
- Prognostic Factors17▲ 6.9×9 topics
- Cancer Therapy17▲ 5.0×15 topics
- Tumor Microenvironment17▲ 6.3×7 topics
- Antibody Engineering15▲ 48×1 topic
- Fc Receptors15▲ 48×1 topic
- Monoclonal Antibody15▲ 47×2 topics
- Medicinal Chemistry14▲ 9.1×9 topics
- Neoadjuvant Therapy14▲ 10×5 topics
- Biopharmaceuticals14▲ 46×3 topics
- Guidelines13▲ 4.7×5 topics
- Immunogenicity13▲ 51×2 topics
- Cell Culture13▲ 18×3 topics
- Bladder Cancer12▲ 51×1 topic
- Urothelial Carcinoma12▲ 44×1 topic
- Resistance Mechanisms11▲ 22×3 topics
- Genomic Profiling11▲ 18×2 topics
- Metastatic11▲ 28×2 topics
- Treatment Guidelines11▲ 8.5×2 topics
- ALK Inhibitors11▲ 30×1 topic
- EGFR Mutations11▲ 30×1 topic
- Recombinant Proteins11▲ 58×2 topics
- Genomic Instability10▲ 15×3 topics
- Pharmacokinetics10▲ 6.3×5 topics
- Stability10▲ 7.5×2 topics
- Protein Aggregation10▲ 31×2 topics
- Chromatography10▲ 108×1 topic
- Refolding10▲ 108×1 topic
- Biopharmaceutical Production9▲ 38×2 topics
- Mammalian Cells9▲ 66×1 topic
- Recombinant Protein9▲ 66×1 topic
- PET Imaging8▲ 8.4×5 topics
Which research topics does Merck KGaA, Darmstadt (Germany) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Bladder and Urothelial Cancer Treatments, Lung Cancer Treatments and Mutations and Protein purification and stability.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 15 works
- 2 Bladder and Urothelial Cancer Treatments Surgery 12 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 11 works
- 4 Protein purification and stability Molecular Biology 10 works
- 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 9 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 8 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 7 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 7 works
- 10 HER2/EGFR in Cancer Research Oncology 6 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Merck KGaA, Darmstadt (Germany)'s research output changed?
Output in 2022-2025 was 8% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Merck KGaA, Darmstadt (Germany) as a percentage of every work published that year, 0.0024% in 2024.
Fractional works of Merck KGaA, Darmstadt (Germany) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.2% in 2002.
Other research institutions in Darmstadt
- Technische Universität Darmstadt
- Darmstadt University of Applied Sciences
- Software (Germany)
- Institut für das Bauen mit Kunststoffen
- Institut für biologische Forschung
- Klinikum Darmstadt
- European Organisation for the Exploitation of Meteorological Satellites
- Zentrum für Foren in der Grafischen Datenverarbeitung
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Merck KGaA, Darmstadt (Germany). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
